CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Clinical Electrical Stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04166630
NCT04166630N/ACompleted

Accelerometer Motion to Measure Muscle Fatigue in Critically Ill Patients

Emory University·interventional·Posted Nov 18, 2019·Updated Aug 19, 2022

In Brief

A clinical study evaluating Clinical Electrical Stimulator for ICU Acquired Weakness. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal muscle will be stimulated with an FDA approved clinical electrical stimulator and accelerations will be passively recorded with an accelerometer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 18, 2019
Enrollment StartFeb 2, 2021
Primary CompletionJun 11, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.6 years ago

Interventions

Clinical Electrical Stimulatordevice

Conductive electrodes will be on the skin at each end of the tested muscle(s). Each subject will have two target muscle groups tested (extensor carpi radialis longus, and tibialis anterior). Each muscle will be stimulated at three separate stimulation frequencies (2 Hz, 4 Hz, and 6Hz) over 3 minutes each, for a total of 9 minutes of stimulation per muscle. The clinical electrical stimulator will deliver mild electrical stimulations to the muscle (20-100 mA).